The combination of anticholinergics and glucocorticoids for the long-term treatment of asthma and COPD

Details for Australian Patent Application No. 2005210085 (hide)

Owner MEDA Pharma GmbH & Co. KG

Inventors Cnota, Peter Jurgen; Szelenyi, Istvan; Maus, Joachim; Goede, Joachim

Agent Spruson & Ferguson

Pub. Number AU-B-2005210085

PCT Pub. Number WO2005/074918

Priority 60/541,956 06.02.04 US

Filing date 24 January 2005

Wipo publication date 18 August 2005

Acceptance publication date 24 June 2010

International Classifications

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/56 (2006.01) - Compounds containing cyclopenta[a]hydrophenanthrene ring systems

A61K 31/573 (2006.01)

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

Event Publications

27 July 2006 PCT application entered the National Phase

  PCT publication WO2005/074918 Priority application(s): WO2005/074918

24 June 2010 Application Accepted

  Published as AU-B-2005210085

21 October 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005210086-Treatment of rhinitis with anticholinergics alone in combination with antihistamines phosphodiesterase 4 inhibitors, or corticosteroids

2005210084-Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treatment of respiratory diseases